Clinical trial · Interventional
Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer
A Randomized Phase II Study of the Nutritional Supplements Juice Plus + and Juice Plus + Complete in Ovarian Cancer Patients
NCT01439659CI-TRIAL-00120556active not recruitingPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical research study is to see if ovarian cancer patients who add Juice PLus+ and Juice Plus+ Complete to their diets have better outcomes when compared to ovarian cancer patients who receive only dietary counseling alone.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Daily Supplements | Dietary Supplement | — | UNRESOLVED |
| Nutritional Counseling | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Nutritional Counseling
- description
- For 6 months control group receives dietary counseling.
- interventionNames
- Behavioral: Nutritional Counseling
- type
- EXPERIMENTAL
- label
- Daily Supplements
- description
- 2 capsules (Juice Plus+) twice a day (morning and evening) plus Juice Plus+ Complete drink each evening for 6 months.
- interventionNames
- Dietary Supplement: Daily Supplements
Primary outcomes (2)
- measure
- Change in serum lipid peroxide levels resulting from nutritional supplements or dietary counseling
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: 1. Body Mass Index (BMI) \> 19.5 2. Epithelial ovarian cancer of (any tumor type). Stages 2 and up. 3. In first clinical remission. (CA125 \< 35) 4. \> 21 years of age. 5. CT scan of abdomen/pelvis without evidence of ovarian cancer. 6. Ambulatory/mobile and able to eat/not on parenteral nutrition. 7. Life expectancy of at least 6 months. 8. Informed consent signed indicating patient's knowledge of the investigational nature of the study. Exclusion Criteria: 1. Evidence of bowel obstruction. 2. Pregnant or lactating. 3. Diagnosed with a co-morbidity requiring a restricted diet or medication for which a high fiber diet may be contraindicated.
References
Publications (0)
Data not yet available
No reference posted for this study.